HealthQuill Drugs
Pfizer announced the availability of its migraine management drug Rimegepant in Hong Kong — the company’s first market in Asia.
Drugs Health Pharma

Pfizer enters Hong Kong migraine market, its first in Asia

HQ Team September 29, 2023: Pfizer announced the availability of its migraine management drug Rimegepant in Hong Kong — the company’s first market.

Read More
Bionomics Limited, a clinical-stage biotechnology company announced positive outcomes for its experimental drug to treat post-traumatic stress disorder (PTSD).
Drugs Health Pharma

Bionomics’ PTSD experimental drug yield positive results in trials

HQ Team September 29, 2023: Bionomics Limited, a clinical-stage biotechnology company announced positive outcomes for its experimental drug to treat post-traumatic stress disorder.

Read More
DIOSynVax, a spin-out company of the University of Cambridge, is in its final stage of human trials of an antigen-based vaccine candidate to treat all coronaviruses.
Drugs Health Pharma

DIOSynVax to finish coronavirus vaccine trial in humans by month-end

HQ Team September 29, 2023: DIOSynVax, a spin-out company of the University of Cambridge, is in its final stage of human trials of.

Read More
The USFDA has issued civil money penalties to 22 retailers selling illegal e-cigarettes and sought up to a maximum of $19,192 fine for a single violation from each retailer.
Drugs Health Pharma

USFDA imposes maximum fine on 22 retailers for selling illegal e-cigarettes

HQ Team September 29, 2023: The USFDA has issued civil money penalties to 22 retailers selling illegal e-cigarettes and sought up to a.

Read More
Merck’s Biological Licence Application for a pulmonary arterial hypertension drug has been accepted for a priority review by the FDA.
Drugs Health Pharma

Merck gets priority review nod from USFDA for hypertension drug 

HQ Team September 28, 2023: Merck’s Biological Licence Application for a pulmonary arterial hypertension drug has been accepted for a priority review by.

Read More
US scientists have honed in on a single chimeric antigen receptor T-cell (CAR T) therapy to cure all forms of blood cancer.
Drugs Health Pharma

US scientists zero in on single blood cancer therapy in animal studies

HQ Team September 28, 2023: US scientists have honed in on a single chimeric antigen receptor T-cell (CAR T) therapy to cure all.

Read More
Swiss biotechnology company, Basilea Pharmaceutica’s last stage trials of ceftobiprole to treat bacterial bloodstream infections have shown favourable outcomes, according to a statement.
Drugs Health Pharma

Swiss firm Basilea reports positive results in late-stage Staph trials

HQ Team September 28, 2023: Swiss biotechnology company, Basilea Pharmaceutica’s last stage trials of ceftobiprole to treat bacterial bloodstream infections have shown favourable.

Read More
Using structural and mechanistic information of two parasitic proteins, scientists have built a new component for a vaccine that may induce an immune response to malaria.
Drugs Health Pharma

NIAD develops protein that may help build new malaria vaccine

HQ Team September 28, 2023: Using structural and mechanistic information of two parasitic proteins, scientists have built a new component for a vaccine.

Read More
Researchers at Sweden’s Lund University have identified a new biomarker to detect Parkinson’s disease before a person develops symptoms.
Drugs Health Pharma

Swedish researchers identify new biomarker to detect Parkinson’s disease

HQ Team September 26, 2023: Researchers at Sweden’s Lund University have identified a new biomarker to detect Parkinson’s disease before a person develops.

Read More
After working on deadly spiders for almost two decades, Brazilian researchers have developed a synthetic molecule from the venom to treat sexual impotence.
Drugs Health Pharma

Brazilian spider venom may help make erectile dysfunction drug

HQ Team September 26, 2023: After working on deadly spiders for almost two decades, Brazilian researchers have developed a synthetic molecule from the.

Read More